| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 3.112 | 9.473 | 15.382 | 14.422 | 19.531 | 26.858 |
| Total Income - EUR | - | - | 0 | 398 | 7.795 | 10.696 | 25.952 | 18.928 | 24.309 | 31.325 |
| Total Expenses - EUR | - | - | 0 | 12.199 | 19.386 | 18.321 | 15.034 | 16.622 | 18.812 | 19.618 |
| Gross Profit/Loss - EUR | - | - | 0 | -11.801 | -11.591 | -7.625 | 10.918 | 2.306 | 5.496 | 11.708 |
| Net Profit/Loss - EUR | - | - | 0 | -11.801 | -11.622 | -7.718 | 10.764 | 2.169 | 5.301 | 10.902 |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dentavid Rx S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 42.580 | 48.958 | 41.813 | 34.808 | 28.889 | 20.916 | 13.868 |
| Current Assets | - | - | 44 | 107 | 311 | 2.428 | 2.302 | 439 | 997 | 320 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 21 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 142 | 1.582 | 1.735 | 419 | 55 | 83 |
| Cash | - | - | 44 | 107 | 169 | 846 | 546 | 21 | 943 | 237 |
| Shareholders Funds | - | - | 44 | -11.758 | -23.152 | -30.431 | -18.992 | -16.882 | -11.530 | -564 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 11.865 | 35.348 | 37.920 | 30.734 | 25.271 | 17.345 | 3.211 |
| Income in Advance | - | - | 0 | 42.580 | 37.073 | 36.753 | 25.367 | 20.940 | 16.098 | 11.541 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dentavid Rx S.r.l.